{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:44:38Z","timestamp":1791247478510,"version":"4.1.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","award":["2024JY004"],"award-info":[{"award-number":["2024JY004"]}],"id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["8 2404609"],"award-info":[{"award-number":["8 2404609"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010820","name":"Suzhou University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"Youth Science Fund Project","doi-asserted-by":"publisher","award":["82404609"],"award-info":[{"award-number":["82404609"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151352","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:02:10Z","timestamp":1773126130000},"page":"151352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CRISPR-based correction of apolipoprotein E4 in Alzheimer's disease: Therapeutic strategies and macromolecular delivery innovations"],"prefix":"10.1016","volume":"354","author":[{"given":"Mingmei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dou","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingcheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0010","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer\u2019s disease facts and figures","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0020","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1021\/acsomega.4c05527","article-title":"Newer therapeutic approaches in treating Alzheimer's disease: a comprehensive review","volume":"10","author":"Reddi Sree","year":"2025","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","article-title":"Alzheimer\u2019s disease, a multifactorial disorder seeking multitherapies","volume":"6","author":"Iqbal","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0030","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1007\/s12035-024-04384-1","article-title":"Recent insights into the neurobiology of Alzheimer\u2019s disease and advanced treatment strategies","volume":"62","author":"Anitha","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12031-025-02337-4","article-title":"Unraveling the complexity of Alzheimer\u2019s disease: insights into etiology and advancements in treatment strategies","volume":"75","author":"Khan","year":"2025","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10048-025-00821-y","article-title":"Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms","volume":"26","author":"Abbas","year":"2025","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: a promising genome editing therapeutic tool for Alzheimer's disease-a narrative review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151352_bb0055","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","article-title":"Alzheimer\u2019s disease genetic risk factor APOE-\u03b54 also affects normal brain function","volume":"13","author":"Di Battista","year":"2016","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2417515122","article-title":"Suppressing APOE4-induced neural pathologies by targeting the VHL-HIF axis","volume":"122","author":"Jiang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.tcb.2023.09.004","article-title":"The cell biology of APOE in the brain","volume":"34","author":"Windham","year":"2024","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0070","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/13872877251360321","article-title":"From APOE to cellular changes: unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease","volume":"107","author":"Jiang","year":"2025","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151352_bb0080","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1007\/s11033-021-06581-w","article-title":"The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics","volume":"48","author":"Dlouha","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0085","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s12035-021-02638-w","article-title":"CRISPR-Cas9-mediated gene therapy in neurological disorders","volume":"59","author":"Guan","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrg.2016.28","article-title":"Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases","volume":"17","author":"Tsai","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151352_bb0095","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.7150\/thno.43360","article-title":"Advances in CRISPR\/Cas-based gene therapy in human genetic diseases","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0100","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s12276-024-01212-3","article-title":"Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0105","doi-asserted-by":"crossref","first-page":"1553590","DOI":"10.3389\/fgeed.2025.1553590","article-title":"CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders","volume":"7","author":"Cabr\u00e9-Romans","year":"2025","journal-title":"Front Genome Ed."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151352_bb0110","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1007\/s12035-024-04143-2","article-title":"Application of CRISPR\/Cas9 system in the treatment of Alzheimer\u2019s disease and neurodegenerative diseases","volume":"61","author":"Rahimi","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0115","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/genes14040908","article-title":"Highly efficient A-to-G editing in PFFs via multiple ABEs","volume":"14","author":"Jing","year":"2023","journal-title":"Genes (Basel)"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.151352_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186867","article-title":"Human pluripotent stem cell-derived neural cells as a relevant platform for drug screening in Alzheimer\u2019s disease","volume":"21","author":"Garcia-Leon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0125","first-page":"567","article-title":"CRISPR\/Cas9 genome editing for neurodegenerative diseases","volume":"22","author":"Nouri Nojadeh","year":"2023","journal-title":"EXCLI J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0130","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/ijms22031244","article-title":"APOE: the new frontier in the development of a therapeutic target towards precision medicine in late-onset Alzheimer\u2019s","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0135","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat. Med."},{"issue":"189","key":"10.1016\/j.ijbiomac.2026.151352_bb0140","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.24976\/Discov.Med.202436189.179","article-title":"Role of apolipoprotein E in Alzheimer's disease pathogenesis, prognosis and treatment","volume":"36","author":"Reiss","year":"2024","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0145","first-page":"223","article-title":"Molecular dynamics of apolipoprotein genotypes APOE4 and SNARE family proteins and their impact on Alzheimer\u2019s disease","volume":"vol. 15","author":"Wang","year":"2025","journal-title":"Life (Basel, Switz.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108572","article-title":"ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism","volume":"34","author":"Qi","year":"2021","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0155","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.stemcr.2021.07.017","article-title":"APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and A\u03b2 generation","volume":"16","author":"Lee","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151352_bb0160","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1007\/s12035-023-03529-y","article-title":"Reexamining the causes and effects of cholesterol deposition in the brains of patients with Alzheimer\u2019s disease","volume":"60","author":"Hu","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41398-022-01881-6","article-title":"Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice","volume":"12","author":"Miranda","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0170","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1007\/s12035-024-04449-1","article-title":"Apolipoprotein E in Alzheimer\u2019s disease: focus on synaptic function and therapeutic strategy","volume":"62","author":"Qu","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70306","article-title":"Sequential proteomic analysis reveals the Key APOE4-induced pathological and molecular features at the presymptomatic stage in Alzheimer\u2019s disease mice","volume":"31","author":"Wei","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer\u2019s disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies","volume":"24","author":"Pires","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms","volume":"17","author":"Koutsodendris","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151352_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111200","article-title":"APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-\u03baB activation","volume":"40","author":"Arnaud","year":"2022","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151352_bb0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-024-00988-2","article-title":"Multifaceted roles of APOE in Alzheimer disease","volume":"20","author":"Jackson","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","article-title":"Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities","volume":"20","author":"Belaidi","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"8006","key":"10.1016\/j.ijbiomac.2026.151352_bb0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer's disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"issue":"7937","key":"10.1016\/j.ijbiomac.2026.151352_bb0210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","article-title":"APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes","volume":"611","author":"Blanchard","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","article-title":"Cell type-specific roles of APOE4 in Alzheimer disease","volume":"25","author":"Blumenfeld","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110670","article-title":"ApoE4-mediated blood-brain barrier damage in Alzheimer\u2019s disease: progress and prospects","volume":"199","author":"Zhou","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-025-00478-5","article-title":"Blood-brain barrier disruption: a pervasive driver and mechanistic link between traumatic brain injury and Alzheimer's disease","volume":"14","author":"Sun","year":"2025","journal-title":"Transl. Neurodegener."},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2026.151352_bb0230","article-title":"An apolipoprotein E receptor mimetic peptide decreases blood-brain barrier permeability following intracerebral hemorrhage by inhibiting the CypA\/MMP-9 signaling pathway via LRP1 activation","volume":"143","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151352_bb0235","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1038\/s41380-020-00956-4","article-title":"C\/EBP\u03b2 is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer\u2019s disease","volume":"26","author":"Xia","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102212","article-title":"Neuronal ApoE4 stimulates C\/EBP\u03b2 activation, promoting Alzheimer\u2019s disease pathology in a mouse model","volume":"209","author":"Wang","year":"2022","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s43587-024-00790-1","article-title":"EBP1 potentiates amyloid \u03b2 pathology by regulating \u03b3-secretase","volume":"5","author":"Kim","year":"2025","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-025-01742-6","article-title":"Differential effects of aging, Alzheimer\u2019s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults","volume":"17","author":"Fischer","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0255","article-title":"Understanding recent advances in non-amyloid\/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease","volume":"10","author":"Van Eldik","year":"2024","journal-title":"Alzheim. Dementia (N. Y. N. Y.)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14357","article-title":"Alzheimer\u2019s disease diagnostic accuracy by fluid and neuroimaging ATN framework","volume":"30","author":"Xiong","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060948","article-title":"Transcriptional and chromatin accessibility profiling of neural stem cells differentiating into astrocytes reveal dynamic signatures affected under inflammatory conditions","volume":"12","author":"Pavlou","year":"2023","journal-title":"Cells"},{"issue":"8005","key":"10.1016\/j.ijbiomac.2026.151352_bb0270","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41586-024-07187-5","article-title":"Disease-associated astrocyte epigenetic memory promotes CNS pathology","volume":"627","author":"Lee","year":"2024","journal-title":"Nature"},{"issue":"S12","key":"10.1016\/j.ijbiomac.2026.151352_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/alz.080373","article-title":"A CLU\/APOJ GWAS AD risk variant suppresses the astrocytic response to plaques and reduces axonal and neuritic damage in 5xFAD mice","volume":"19","author":"Milinkeviciute","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0280","article-title":"Bromelain prevents Alzheimer\u2019s disease progression by suppressing oxidative stress and upregulating apolipoprotein A1 in 5x familial Alzheimer\u2019s disease transgenic mice","volume":"21","author":"Hsu","year":"2025","journal-title":"J. Agric. Food Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151352_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100667","article-title":"Apolipoprotein B gene expression and regulation in relation to Alzheimer\u2019s disease pathophysiology","volume":"65","author":"Aumont-Rodrigue","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0290","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/pathophysiology31040040","article-title":"Pathways to Alzheimer\u2019s disease: the intersecting roles of clusterin and apolipoprotein E in amyloid-\u03b2 regulation and neuronal health","author":"Laslo","year":"2024","journal-title":"Pathophysiology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0295","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/jnc.15170","article-title":"High-density lipoprotein-related cholesterol metabolism in Alzheimer\u2019s disease","volume":"159","author":"Pedrini","year":"2021","journal-title":"J. Neurochem."},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2026.151352_bb0300","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1159\/000530774","article-title":"HMGB1 is a prognostic factor for mortality in acute kidney injury requiring renal replacement therapy","volume":"52","author":"Matsuura","year":"2023","journal-title":"Blood Purif."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0305","article-title":"Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes","volume":"1867","author":"Azizidoost","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151352_bb0310","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14728222.2023.2235718","article-title":"The role of the ATP-Binding Cassette A1 (ABCA1) in neurological disorders: a mechanistic review","volume":"27","author":"Paseban","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.151352_bb0315","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/acschemneuro.0c00637","article-title":"Apolipoprotein J in Alzheimer\u2019s disease: shedding light on its role with cell signaling pathway perspective and possible therapeutic approaches","volume":"11","author":"Moezzi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0320","series-title":"Biochemical and Clinical Characterization of Genetic Risk Factors of Alzheimer's Disease","author":"Tedeschi Dauar","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0325","series-title":"Deciphering the Molecular Interactions of Blood-borne Lipoproteins With the Brain Vasculature","first-page":"155","author":"Kakava","year":"2025"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12944-021-01605-7","article-title":"CRISPR\/Cas9-mediated knockout of APOC3 stabilizes plasma lipids and inhibits atherosclerosis in rabbits","volume":"20","author":"Zha","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0335","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/MS9.0000000000001692","article-title":"Role and application of CRISPR-Cas9 in the management of Alzheimer\u2019s disease","volume":"86","author":"Soni","year":"2012","journal-title":"Ann. Med. Surg."},{"issue":"S9","key":"10.1016\/j.ijbiomac.2026.151352_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/alz.036578","article-title":"Allele specific targeting of APOE-E4 expression: the novel CRISRP\/CAS9-based platform for precision therapy for Alzheimer\u2019s disease","volume":"16","author":"Kantor","year":"2020","journal-title":"Alzheimers Dement."},{"issue":"F","key":"10.1016\/j.ijbiomac.2026.151352_bb0345","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3889\/oamjms.2022.9053","article-title":"A Review of CRISPR Cas9 for Alzheimer\u2019s disease: treatment strategies and could target APOE e4, APP, and PSEN-1 gene using CRISPR cas9 prevent the patient from Alzheimer\u2019s disease?","volume":"10","author":"Adji","year":"2022","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0350","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/cells14040243","article-title":"From genetics to neuroinflammation: the impact of ApoE4 on microglial function in Alzheimer's disease","volume":"14","author":"Dias","year":"2025","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14433","article-title":"Retinal dysfunction in APOE4 knock-in mouse model of Alzheimer\u2019s disease","volume":"21","author":"Abhyankar","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151352_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113183","article-title":"ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes","volume":"42","author":"Lee","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13287-019-1342-6","article-title":"Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR\/Cas-mediated genetic correction, and productive hepatitis C virus infection","volume":"10","author":"Caron","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0370","first-page":"1670","article-title":"The use of base editing technology to characterize single nucleotide variants, Computational and Structural","volume":"20","author":"McDaniel","year":"2022","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0375","series-title":"Successful Gene Editing of Apolipoprotein E4 to E3 in Brain of Alzheimer Model Mice After a Single IV Dose of Synthetic Exosome-Delivered CRISPR","author":"Teter","year":"2024"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0380","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1038\/s41467-021-23081-4","article-title":"Author correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0385","first-page":"416","article-title":"Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editor","volume":"14","author":"Wei","year":"2023","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.151352_bb0395","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae759","article-title":"Learning to quantify uncertainty in off-target activity for CRISPR guide RNAs","volume":"52","author":"\u00d6zden","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0400","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41467-025-57154-5","article-title":"Improving adenine base editing precision by enlarging the recognition domain of CRISPR-Cas9","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151352_bb0405","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","article-title":"Designing and executing prime editing experiments in mammalian cells","volume":"17","author":"Doman","year":"2022","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0410","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0415","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/crispr.2024.0028","article-title":"Enrichment of allelic editing outcomes by prime editing in induced pluripotent stem cells","volume":"7","author":"Niwa","year":"2024","journal-title":"CRISPR J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2024.11.002","article-title":"Optimized prime editing of the Alzheimer's disease-associated APOE4 mutation","volume":"20","author":"Rottner","year":"2025","journal-title":"Stem Cell Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0425","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/alz.13075","article-title":"Ancestry-related differences in chromatin accessibility and gene expression of APOE \u03b54 are associated with Alzheimer\u2019s disease risk","volume":"19","author":"Celis","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15283\/ijsc23030","article-title":"Recent research trends in stem cells using CRISPR\/Cas-based genome editing methods","volume":"17","author":"Yoon","year":"2024","journal-title":"Int. J. Stem Cells"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0435","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.stemcr.2023.08.002","article-title":"Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model","volume":"18","author":"Watanabe","year":"2023","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0440","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-022-01006-x","article-title":"Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer\u2019s tau pathology","volume":"7","author":"Huang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6451","key":"10.1016\/j.ijbiomac.2026.151352_bb0445","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1126\/science.aax7063","article-title":"A cytosine deaminase for programmable single-base RNA editing","volume":"365","author":"Abudayyeh","year":"2019","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0450","series-title":"Reelin Marks Cocaine-activated Striatal Ensembles, Promotes Neuronal Excitability, and Regulates Cocaine Reward","first-page":"599348","volume":"17","author":"Brida","year":"2024"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0455","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s11658-023-00504-2","article-title":"Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer\u2019s disease","volume":"28","author":"Marei","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0460","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","article-title":"Human iPSC-derived neural models for studying Alzheimer\u2019s disease: from neural stem cells to cerebral organoids","volume":"18","author":"Barak","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"583","key":"10.1016\/j.ijbiomac.2026.151352_bb0465","doi-asserted-by":"crossref","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","article-title":"APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia","volume":"13","author":"Sienski","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0470","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.stemcr.2022.03.018","article-title":"APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes","volume":"17","author":"de Leeuw","year":"2022","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0475","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3233\/JAD-230514","article-title":"The role of impaired receptor trafficking in mediating the pathological effects of APOE4 in Alzheimer's disease","volume":"97","author":"Safieh","year":"2024","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102441","article-title":"Modeling and correction of protein conformational disease in iPSC-derived neurons through personalized base editing","volume":"36","author":"Konishi","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151352_bb0485","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1016\/j.stemcr.2021.10.017","article-title":"Simultaneous high-efficiency base editing and reprogramming of patient fibroblasts","volume":"16","author":"Jalil","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0490","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00401-021-02361-9","article-title":"Apolipoprotein E regulates lipid metabolism and \u03b1-synuclein pathology in human iPSC-derived cerebral organoids","volume":"142","author":"Zhao","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"S3","key":"10.1016\/j.ijbiomac.2026.151352_bb0495","article-title":"Interrogating the role of APOE4 in Alzheimer\u2019s disease and Down syndrome using human induced pluripotent stem cells (hiPSC)-derived cerebral organoids","volume":"18","author":"Dooling","year":"2022","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0500","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.stem.2024.10.005","article-title":"Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model","volume":"32","author":"Rao","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0505","first-page":"19","article-title":"The versatile applications of human pluripotent stem cell-derived microglia and microglia-containing brain organoids","volume":"3","author":"Junjiao","year":"2023","journal-title":"Ageing Neurodegen. Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151352_bb0510","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","article-title":"Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity","volume":"29","author":"Victor","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"S4","key":"10.1016\/j.ijbiomac.2026.151352_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/alz.060213","article-title":"APOE allele switching in a novel transgenic mouse model as a therapeutic approach for Alzheimer\u2019s disease","volume":"18","author":"Golden","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12868-024-00901-z","article-title":"APOE4 rat model of Alzheimer\u2019s disease: sex differences, genetic risk and diet","volume":"25","author":"Colarusso","year":"2024","journal-title":"BMC Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0525","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ana.27149","article-title":"Inhibition of bone morphogenetic protein signaling prevents Tau pathology in iPSC derived neurons and PS19 mice","volume":"97","author":"Affaneh","year":"2025","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0530","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s12964-024-01832-2","article-title":"Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE","volume":"22","author":"Yesiltepe","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.151352_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25136901","article-title":"Comprehensive overview of Alzheimer\u2019s disease: etiological insights and degradation strategies","volume":"25","author":"Singh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0540","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-240058","article-title":"Addressing the discrepancies between animal models and human Alzheimer's disease pathology: implications for translational research","volume":"98","author":"Polis","year":"2024","journal-title":"J. Alzheimer's Dis"},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2026.151352_bb0545","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00335-017-9687-6","article-title":"Bridging the gap: large animal models in neurodegenerative research","volume":"28","author":"Eaton","year":"2017","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0550","series-title":"Application of Nanocarriers in Brain Delivery of Therapeutics","first-page":"315","article-title":"In vivo animal models development and their limitations for brain research","author":"Mangrulkar","year":"2024"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151352_bb0555","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1194\/jlr.M085985","article-title":"Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques","volume":"59","author":"Anantharamaiah","year":"2018","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0560","doi-asserted-by":"crossref","first-page":"22130","DOI":"10.1038\/s41598-021-01480-3","article-title":"Apolipoprotein E levels in the amygdala and prefrontal cortex predict relative regional brain volumes in irradiated Rhesus macaques","volume":"11","author":"Kundu","year":"2021","journal-title":"Surf. Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0565","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ame2.12092","article-title":"Current state of research on non-human primate models of Alzheimer's disease","volume":"2","author":"Li","year":"2019","journal-title":"Anim. Mod. Exp. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0570","doi-asserted-by":"crossref","first-page":"263","DOI":"10.24272\/j.issn.2095-8137.2023.197","article-title":"Genetically modified non-human primate models for research on neurodegenerative diseases","volume":"45","author":"Pan","year":"2024","journal-title":"Zool. Res."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.913996","article-title":"Gene editing monkeys: retrospect and outlook","volume":"10","author":"Liang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0580","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.24272\/j.issn.2095-8137.2022.289","article-title":"Animal models of Alzheimer\u2019s disease: Applications, evaluation, and perspectives","volume":"43","author":"Chen","year":"2022","journal-title":"Zool. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177933","article-title":"Production of transgenic pig as an Alzheimer's disease model using a multi-cistronic vector system","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100740","article-title":"A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency","volume":"3","author":"Andersen","year":"2022","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0595","article-title":"PET imaging in animal models of alzheimer\u2019s disease","volume":"16","author":"Chen","year":"2022","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0600","article-title":"Drug permeability: from the blood-brain barrier to the peripheral nerve barriers","volume":"6","author":"Sun","year":"2023","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0605","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12987-024-00580-2","article-title":"iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta","volume":"21","author":"Ding","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0610","series-title":"Increased Tau Expression in the APOE4 Blood-Brain Barrier Model is Associated With Reduced Anti-Tau Therapeutic Antibody Delivery in Vitro","first-page":"24.563706","volume":"10","author":"Wasielewska","year":"2023"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0615","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41434-021-00244-y","article-title":"Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9","volume":"29","author":"Chatterjee","year":"2022","journal-title":"Gene Ther."},{"issue":"34","key":"10.1016\/j.ijbiomac.2026.151352_bb0620","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302910120","article-title":"Focused ultrasound-mediated brain genome editing","volume":"120","author":"Lao","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151352_bb0625","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1080\/15548627.2020.1851897","article-title":"Autophagy alleviates hypoxia-induced blood-brain barrier injury via regulation of CLDN5 (claudin 5)","volume":"17","author":"Yang","year":"2021","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151352_bb0630","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1091\/mbc.E20-07-0464","article-title":"Occludin and tricellulin facilitate formation of anastomosing tight-junction strand network to improve barrier function","volume":"32","author":"Saito","year":"2021","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0635","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.4103\/1673-5374.331538","article-title":"The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer\u2019s disease","volume":"17","author":"Dias","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215172","article-title":"Vector enabled CRISPR gene editing - a revolutionary strategy for targeting the diversity of brain pathologies","volume":"487","author":"Forgham","year":"2023","journal-title":"Coord. Chem. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0645","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1038\/s41467-024-50515-6","article-title":"The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders","volume":"15","author":"Kantor","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0650","article-title":"Delivery Platforms for CRISPR\/Cas9 genome editing of glial cells in the central nervous system","volume":"3","author":"Meneghini","year":"2021","journal-title":"Front. Genome Edit."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.151352_bb0655","doi-asserted-by":"crossref","first-page":"eabm8011","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16091197","article-title":"Advances in nanoparticles as non-viral vectors for efficient delivery of CRISPR\/Cas9","volume":"16","author":"Kim","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0665","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2147\/IJN.S457393","article-title":"Advancing CNS therapeutics: enhancing neurological disorders with nanoparticle-based gene and enzyme replacement therapies","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0670","first-page":"239","article-title":"Non-viral systems for intracellular delivery of genome editing tools","volume":"28","author":"Shaikhutdinov","year":"2024","journal-title":"Vavilovskii Zhurn. Genet. Selektsii"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0675","doi-asserted-by":"crossref","first-page":"1578138","DOI":"10.3389\/fncel.2025.1578138","article-title":"CRISPR\/Cas9-based therapeutics as a promising strategy for management of Alzheimer\u2019s disease: progress and prospects","volume":"19","author":"Khan","year":"2025","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0680","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s44258-023-00004-0","article-title":"Non-viral approaches for gene therapy and therapeutic genome editing across the blood-brain barrier","volume":"1","author":"Xie","year":"2023","journal-title":"Med-X"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102420","article-title":"An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia models","volume":"20","author":"Meier","year":"2025","journal-title":"Stem Cell Rep."},{"issue":"01","key":"10.1016\/j.ijbiomac.2026.151352_bb0690","doi-asserted-by":"crossref","DOI":"10.30651\/jqm.v8i01.16054","article-title":"Tandem peptide lipid CRISPR-Cas9 complex combating APP and APOE4 gene abnormality in Alzheimer's disease","volume":"8","author":"Rahmanto","year":"2024","journal-title":"Qanun Medika"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114298","article-title":"Exosome-Based Macromolecular neurotherapeutic drug delivery approaches in overcoming the blood-brain barrier for treating brain disorders","volume":"199","author":"Yadav","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0700","series-title":"Development of Non-Viral Vectors for Neuronal-targeting of Crispr as a Therapeutic Strategy for Neurological Disorders","author":"Shalaby","year":"2022"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0705","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1038\/s41380-024-02837-6","article-title":"The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage","volume":"30","author":"Chen","year":"2025","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0710","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/s41467-022-31791-6","article-title":"Efficient spatially targeted gene editing using a near-infrared activatable protein-conjugated nanoparticle for brain applications","volume":"13","author":"Rebelo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121959","article-title":"Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins","volume":"293","author":"Metzger","year":"2023","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151352_bb0720","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00018-023-05026-w","article-title":"Molecular modeling of apoE in complexes with Alzheimer\u2019s amyloid-\u03b2 fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids","volume":"80","author":"Lewkowicz","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.crmeth.2022.100290","article-title":"Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells","volume":"2","author":"Haideri","year":"2022","journal-title":"Cell Reports Methods"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0730","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jconrel.2024.09.019","article-title":"RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells","volume":"375","author":"Rouatbi","year":"2024","journal-title":"J. Control. Release"},{"issue":"44","key":"10.1016\/j.ijbiomac.2026.151352_bb0735","doi-asserted-by":"crossref","first-page":"30293","DOI":"10.1021\/acsnano.4c05169","article-title":"Widespread gene editing in the brain via in utero delivery of mRNA using acid-degradable lipid nanoparticles","volume":"18","author":"Gao","year":"2024","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.151352_bb0740","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1039\/D2BM00368F","article-title":"Development of non-viral vectors for neuronal-targeted delivery of CRISPR-Cas9 RNA-proteins as a therapeutic strategy for neurological disorders","volume":"10","author":"Shalaby","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0745","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.actbio.2024.10.030","article-title":"A biodegradable lipid nanoparticle delivers a Cas9 ribonucleoprotein for efficient and safe in situ genome editing in melanoma","volume":"190","author":"Yang","year":"2024","journal-title":"Acta Biomater."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.151352_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810672","article-title":"CRISPR\/nCas9-based genome editing on gm2 gangliosidoses fibroblasts via Non-Viral Vectors","volume":"23","author":"Leal","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0755","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70120","article-title":"Management of Alzheimer\u2019s disease with nanotechnological interventions and novel therapeutics","volume":"86","author":"Shahrukh","year":"2025","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0760","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2022.08.042","article-title":"LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea","volume":"350","author":"Mirjalili Mohanna","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0765","series-title":"Engineering Biomaterials for Neural Applications","first-page":"229","article-title":"Polymer-mediated delivery of CRISPR-Cas9 genome-editing therapeutics for CNS disease","author":"Iqbal","year":"2022"},{"issue":"32","key":"10.1016\/j.ijbiomac.2026.151352_bb0770","first-page":"e2309314","article-title":"Lipid-polymer nanoparticles mediate compartmentalized delivery of Cas9 and sgRNA for glioblastoma vasculature and immune reprogramming","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0775","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.7150\/thno.46992","article-title":"Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice","volume":"11","author":"Xie","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0780","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41551-021-00759-0","article-title":"Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer\u2019s disease alleviates amyloid-related pathologies in mice","volume":"6","author":"Duan","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0785","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0790","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/pharmaceutics17020201","article-title":"Non-invasive delivery of CRISPR\/Cas9 ribonucleoproteins (Cas9 RNPs) into cells via nanoparticles for membrane transport","volume":"17","author":"Tashima","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0795","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/nyas.14907","article-title":"Uncovering mechanisms of brain inflammation in Alzheimer\u2019s disease with APOE4: application of single cell-type lipidomics","volume":"1518","author":"Asante","year":"2022","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0800","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204243","article-title":"Generation of APOE knock-down SK-N-SH human neuroblastoma cells using CRISPR\/Cas9: a novel cellular model relevant to Alzheimer\u2019s disease research","volume":"41","author":"Mu\u00f1oz","year":"2021","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0805","first-page":"273","article-title":"Cre-recombinase systems for induction of neuron-specific knockout models: a guide for biomedical researchers","volume":"18","author":"Shcholok","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151352_bb0810","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","article-title":"Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory","volume":"109","author":"Li","year":"2021","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151352_bb0815","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/s44321-024-00162-7","article-title":"APOE from astrocytes restores Alzheimer\u2019s A\u03b2-pathology and DAM-like responses in APOE deficient microglia","volume":"16","author":"Preman","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0820","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2022.03.011","article-title":"ApoE4 reduction: an emerging and promising therapeutic strategy for Alzheimer\u2019s disease","volume":"115","author":"Li","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0830","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.apsb.2024.10.009","article-title":"Microglial APOE4 promotes neuron degeneration in Alzheimer\u2019s disease through inhibition of lipid droplet autophagy","volume":"15","author":"Mao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0835","series-title":"An Arrayed CRISPR\/Cas9 Screen Identifies mTORC1 as a Regulator of Lipid Droplet Accumulation in APOE E3 and APOE KO iPSC-derived Microglia","author":"Meier","year":"2024"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151352_bb0840","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.immuni.2024.09.014","article-title":"Apolipoprotein E aggregation in microglia initiates Alzheimer's disease pathology by seeding \u03b2-amyloidosis","volume":"57","author":"Kaji","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0845","series-title":"The Alzheimer\u2019s Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states","author":"Rosner","year":"2024"},{"issue":"S13","key":"10.1016\/j.ijbiomac.2026.151352_bb0850","doi-asserted-by":"crossref","DOI":"10.1002\/alz.080541","article-title":"Generation of microglia-containing APOE4 cerebral organoids as a model of Down syndrome associated Alzheimer\u2019s disease","volume":"19","author":"Summers","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb0855","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.ymthe.2025.03.057","article-title":"Current trends in gene therapy to treat inherited disorders of the brain","volume":"33","author":"Matuszek","year":"2025","journal-title":"Mol. Ther."},{"issue":"6662","key":"10.1016\/j.ijbiomac.2026.151352_bb0860","doi-asserted-by":"crossref","first-page":"eadk5693","DOI":"10.1126\/science.adk5693","article-title":"Neurodegeneration enters the era of functional genomics","volume":"381","author":"Aguzzi","year":"2023","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151352_bb0865","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/brainsci15070675","article-title":"The APOE\u2013microglia axis in Alzheimer\u2019s disease: functional divergence and therapeutic perspectives\u2014a narrative review","volume":"15","author":"Liu","year":"2025","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0870","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-025-00802-7","article-title":"Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD","volume":"20","author":"Wang","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.151352_bb0875","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.7150\/thno.112661","article-title":"Alisol A ameliorates vascular cognitive impairment via AMPK\/NAMPT\/SIRT1-mediated regulation of cholesterol and autophagy","volume":"15","author":"Xu","year":"2025","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0880","first-page":"514","article-title":"Insulin signalling regulates Pink1 mRNA localization via modulation of AMPK activity to support PINK1 function in neurons, Nature","volume":"6","author":"Hees","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116296","article-title":"Geniposide effectively safeguards HT22 cells against A\u03b2-induced damage by activating mitophagy via the PINK1\/Parkin signaling pathway","volume":"226","author":"Ye","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151352_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113183","article-title":"ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes","volume":"42","author":"Lee","year":"2023","journal-title":"Cell Rep."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.151352_bb0895","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1021\/acs.jmedchem.4c00733","article-title":"Nonlipogenic ABCA1 inducers (NLAI) for Alzheimer\u2019s disease validated in a mouse model expressing human APOE3\/APOE4","volume":"67","author":"Velma","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0900","doi-asserted-by":"crossref","unstructured":"C.R. Lysaker, Ceomic and Metabolic Profiling Reveals APOE4-dependent Shifts in Whole Brain, Neuronal, and Astrocytic Mitochondrial Function and Glycolysis, bioRxiv (2025) 2025.06. 15.659811.","DOI":"10.1101\/2025.06.15.659811"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0905","series-title":"Neurobehavioral Effects of bdnf gene Silencing via Intracerebroventricular Delivery of Nanobioconjugated CRISPRi dCas9\/KRAB in adult brain of female Poecilia reticulata[J]","author":"V\u00e1squez Hu\u00e9rfano","year":"2025"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb0910","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","article-title":"Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits","volume":"3","author":"Koutsodendris","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0915","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.omtn.2021.02.032","article-title":"Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro, molecular therapy","volume":"24","author":"Guyon","year":"2021","journal-title":"Nucleic Acids"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0920","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40035-024-00415-y","article-title":"CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy","volume":"13","author":"Gee","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151352_bb0925","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/antiox14070781","article-title":"CRISPR\/Cas9 and iPSC-based therapeutic approaches in Alzheimer\u2019s disease","volume":"14","author":"Raffaele","year":"2025","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0930","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41467-020-15053-x","article-title":"Multiplexed CRISPR technologies for gene editing and transcriptional regulation","volume":"11","author":"Bhardwaj","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123019","article-title":"Engineered exosome therapeutics for neurodegenerative diseases","volume":"356","author":"Saikia","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0940","series-title":"In Vivo CRISPR Base Editing for Treatment of Huntington\u2019s Disease","author":"Shirguppe","year":"2024"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151352_bb0945","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.ymthe.2018.04.017","article-title":"In situ gene therapy via AAV-CRISPR-Cas9-mediated targeted gene regulation","volume":"26","author":"Moreno","year":"2018","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151352_bb0950","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41579-022-00739-4","article-title":"Structural biology of CRISPR-Cas immunity and genome editing enzymes","volume":"20","author":"Wang","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0955","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s40478-025-02121-w","article-title":"In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies","volume":"13","author":"Fouka","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151352_bb0960","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.7150\/thno.109625","article-title":"Investigating the relationships of structural and functional neural networks of primary visual cortex with engineered AAVs and chemogenetic-fMRI techniques","volume":"15","author":"Gui","year":"2025","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151352_bb0965","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s11095-025-03931-2","article-title":"Key challenges and optimization practices for non-clinical evaluation of AAV based gene therapy for central nervous system disease","volume":"42","author":"Dou","year":"2025","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115285","article-title":"Dynein-regulated brain transduction of AAV.CAP-B10 via cerebral lateral ventricle enhances hippocampal function after traumatic brain injury through Ngf gene delivery in mice","volume":"391","author":"Wang","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151352_bb0975","series-title":"Genome Editing for Neurodegenerative Diseases","first-page":"1","article-title":"Chapter one - therapeutic potential of genome editing tools in neurodegenerative diseases","author":"Kumar","year":"2025"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101365","article-title":"Comprehensive analysis of off-target and on-target effects resulting from liver-directed CRISPR-Cas9-mediated gene targeting with AAV vectors","volume":"32","author":"Singh","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151352_bb0985","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/med4.70016","article-title":"Anticipating on-target and off-target effects of CRISPR\/Cas9 genome editing via a feedforward neural network model","volume":"3","author":"Nagendran","year":"2025","journal-title":"Med. Adv."},{"issue":"2025","key":"10.1016\/j.ijbiomac.2026.151352_bb0990","article-title":"Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: addressing neuroinflammation and enhancing clinical translation","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb0995","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1038\/s41467-025-63167-x","article-title":"Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins","volume":"16","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151352_bb1000","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052213","article-title":"Progress in AAV-mediated in vivo gene therapy and its applications in central nervous system diseases","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2025","key":"10.1016\/j.ijbiomac.2026.151352_bb1005","article-title":"Unveiling the therapeutic potential of natural products in Alzheimer\u2019s disease: insights from in vitro, in vivo, and clinical studies","volume":"16","author":"Aktary","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151352_bb1010","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/s41593-025-02043-9","article-title":"CRISPR screening by AAV episome-sequencing (CrAAVe-seq): a scalable cell-type-specific in vivo platform uncovers neuronal essential genes","volume":"28","author":"Ramani","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb1015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41467-023-35886-6","article-title":"Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing","volume":"14","author":"Tao","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151352_bb1020","doi-asserted-by":"crossref","DOI":"10.3390\/biom15070935","article-title":"Overcoming immune barriers in allogeneic CAR-NK therapy: from multiplex gene editing to AI-driven precision design","volume":"15","author":"Kim","year":"2025","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151352_bb1025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/0115665232342293241120033251","article-title":"Synergizing CRISPR-Cas9 with advanced artificial intelligence and machine learning for precision drug delivery: technological nexus and regulatory insights","volume":"25","author":"Roy","year":"2025","journal-title":"Curr. Gene Ther."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.151352_bb1030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157364","article-title":"Precision neuro-oncology in glioblastoma: AI-guided CRISPR editing and real-time multi-omics for genomic brain surgery","volume":"26","author":"\u0218erban","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151352_bb1035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13195-025-01811-w","article-title":"A novel biochemical analysis for ApoE4 quantification in plasma and discrimination of homozygous and heterozygous APOE \u03b54 carriers","volume":"17","author":"Rodr\u00edguez","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"s1","key":"10.1016\/j.ijbiomac.2026.151352_bb1040","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.3233\/JAD-240888","article-title":"Pros and Cons of APOE4 homozygosity and effects on neuroplasticity, malnutrition, and infections in early life adversity, Alzheimer's disease, and Alzheimer's prevention","volume":"100","author":"Ori\u00e1","year":"2024","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151352_bb1045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3934\/Neuroscience.2025020","article-title":"Oxidative genomic or genotoxic stress in neurodegeneration: Mechanisms and therapeutic avenues","volume":"12","author":"Uddin","year":"2025","journal-title":"AIMS Neurosci."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.151352_bb1050","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.3390\/molecules30173479","article-title":"Biologics as therapeutical agents under perspective clinical studies for Alzheimer\u2019s disease","volume":"30","author":"Li","year":"2025","journal-title":"Molecules (Basel, Switz.)"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302601278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302601278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:03:58Z","timestamp":1776117838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302601278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":210,"alternative-id":["S014181302601278X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151352","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-based correction of apolipoprotein E4 in Alzheimer's disease: Therapeutic strategies and macromolecular delivery innovations","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151352"}}